JENTADUETO Strength — DIN 02403269
Active ingredient(s) See footnote 8 : Strength LINAGLIPTIN : 2.5 MG METFORMIN HYDROCHLORIDE : 850 MG · BOEHRINGER INGELHEIM (CANADA) LTD LTEE 5180 South Service Road Burlington Ontario Canada L7L 5H4 · Tablet · wholesale supply in Canada
Health Canada status: MARKETED
What is JENTADUETO?
JENTADUETO Strength contains Active ingredient(s) See footnote 8 : Strength LINAGLIPTIN : 2.5 MG METFORMIN HYDROCHLORIDE : 850 MG. It is listed in the Health Canada Drug Product Database under DIN 02403269, held by BOEHRINGER INGELHEIM (CANADA) LTD LTEE 5180 South Service Road Burlington Ontario Canada L7L 5H4, supplied as Tablet for Oral administration. Health Canada currently lists it as marketed, status dated 17-Apr-2013. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is JENTADUETO used for?
JENTADUETO (linagliptin /metformin hydrochloride tablets) is indicated as an adjunct to diet and exercise, to improve glycemic control in adult patients with type 2 diabetes mellitus who are: inadequately controlled on metformin, or already controlled with the free combination of linagliptin and metformin. JENTADUETO (linagliptin/metformin hydrochloride tablets) is indicated as an adjunct to diet and exercise, to improve glycemic control in adult patients with type 2 diabetes mellitus: in combination with a sulfonylurea, when dual therapy with metformin and a sulfonylurea do not provide adequate glycemic control, or in combination with basal insulin, when dual therapy with metformin and basal insulin do not provide adequate glycemic control.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Metformin And Linagliptin cost around the world?
Metformin And Linagliptin is listed on 13 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Austria publishes a KVP (Kassenverkaufspreis); Bahrain publishes a retail (max). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| United States | acquisition | 6 | 172 | USD███.██ |
| Australia | ex-manufacturer | 33 | 96 | AUD███.██ |
| Czechia | max producer price (ex-factory) | 19 | 96 | CZK███.██ |
| Sweden | AIP (pharmacy purchase price) | 14 | 53 | SEK███.██ |
| Austria | KVP (Kassenverkaufspreis) | 13 | 26 | EUR███.██ |
| Romania | max producer price | 19 | 25 | RON███.██ |
| South Africa | single exit price | 11 | 15 | ZAR███.██ |
| Greece | producer price (ex-factory) | 14 | 14 | EUR███.██ |
| United Kingdom | hospital | 10 | 10 | GBP███.██ |
| Hungary | producer price (ex-factory) | 4 | 5 | HUF███.██ |
| Luxembourg | reimbursement | 5 | 5 | EUR███.██ |
| United Arab Emirates | public | 3 | 3 | AED███.██ |
| Bahrain | retail (max) | 3 | 3 | BHD███.██ |
523 pack listings across 154 brand entries and 12 price bases, refreshed 08 Sep 2026. Ranges span every Metformin And Linagliptin pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Metformin And Linagliptin in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
Only one market authorization holder has a Canadian DIN containing Metformin And Linagliptin — 3 DINs, of which 3 are currently marketed. There is no second Canadian source today, so a supply interruption on this holder has no domestic substitute at the same molecule.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| BOEHRINGER INGELHEIM (CANADA) LTD LTEE 5180 South Service Road Burlington Ontario Canada L7L 5H4 | 3 | 3 | JENTADUETO | Sourceable in Canada |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | Strength |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Pack configuration (monograph) | null |
| Storage | STORAGE AND STABILITY section |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Metformin And Linagliptin |
|---|---|
| ATC code | A10BD11 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02403269 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2403269 |
| Brand name | JENTADUETO |
| Generic / active ingredient | Active ingredient(s) See footnote 8 : Strength LINAGLIPTIN : 2.5 MG METFORMIN HYDROCHLORIDE : 850 MG |
| Market authorization holder | BOEHRINGER INGELHEIM (CANADA) LTD LTEE 5180 South Service Road Burlington Ontario Canada L7L 5H4 |
| Health Canada schedule | PRESCRIPTION |
| ATC code | A10BD11 |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A10BD |
| Current status | MARKETED |
| Status date | 17-Apr-2013 |
| Original market date | 2013-04-17 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Individualize dose based on current regimen. Maximum daily dose is 5 mg linagliptin/2000 mg metformin. Take twice daily with meals to reduce GI side effects.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Type 1 diabetes; metabolic acidosis; history of lactic acidosis; severe renal impairment (eGFR <30 mL/min/1.73 m2); hepatic dysfunction; excessive alcohol intake; pregnancy/breastfeeding.
Warnings and precautions
Serious Warning: Lactic acidosis due to metformin accumulation. Risk of heart failure, pancreatitis, and serious hypersensitivity reactions. Discontinue before iodinated contrast studies.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
3 of 3 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| JENTADUETO | Strength | Tablet | BOEHRINGER INGELHEIM (CANADA) LTD LTEE 5180 South Service Road Burlington Ontario Canada L7L 5H4 | MARKETED | 02403250 |
| JENTADUETO | Strength | Tablet | BOEHRINGER INGELHEIM (CANADA) LTD LTEE 5180 South Service Road Burlington Ontario Canada L7L 5H4 | MARKETED | 02403277 |
2 · Same class — other molecules in ATC A10BD
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Metformin And Sitagliptin | AG-SITAGLIPTIN HYDROCHLORIDE / METFORMIN · APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE · APO-SITAGLIPTIN-METFORMIN · APO-SITAGLIPTIN/METFORMIN XR · +19 more | 63 | 46 | Yes |
| Metformin And Dapagliflozin | APO-DAPAGLIFLOZIN-METFORMIN · AURO-DAPAGLIFLOZIN / METFORMIN · XIGDUO | 6 | 6 | Yes |
| Metformin And Empagliflozin | SYNJARDY | 6 | 6 | Yes |
| Metformin And Canagliflozin | INVOKAMET · INVOKAMET XR | 10 | 3 | Yes |
| Metformin And Alogliptin | KAZANO | 3 | 3 | Yes |
| Metformin And Linagliptin | JENTADUETO | 3 | 3 | Yes |
| Metformin And Rosiglitazone | AVANDAMET · PMS-ROSIGLITAZONE-METFORMIN | 10 | 0 | Not in Canada |
| Combinations Of Oral Blood Glucose Lowering Drugs | SEGLUROMET · STEGLUJAN | 6 | 0 | Not in Canada |
| Pioglitazone And Alogliptin | OSENI | 6 | 0 | Not in Canada |
| Metformin And Saxagliptin | KOMBOGLYZE | 3 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC A10B
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| A10BH | Alogliptin · Linagliptin · Saxagliptin · Sitagliptin | 91 | 63 |
| A10BA | Metformin | 122 | 45 |
| A10BK | Canagliflozin · Dapagliflozin · Empagliflozin · Ertugliflozin | 42 | 30 |
| A10BX | Nateglinide · Repaglinide · Tirzepatide | 54 | 30 |
| A10BB | Acetohexamide · Chlorpropamide · Glibenclamide · Gliclazide · Glimepiride · +1 more | 112 | 23 |
| A10BG | Pioglitazone · Rosiglitazone | 98 | 15 |
| A10BJ | Albiglutide · Dulaglutide · Exenatide · Liraglutide · Lixisenatide · +1 more | 34 | 13 |
| A10BF | Acarbose | 6 | 2 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is JENTADUETO called?
The same molecule, Metformin And Linagliptin, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Metformin Sandoz | Latin | Australia, Czechia, Sweden |
| METFORMIN VIATRIS | Latin | Czechia |
| Metformin Accord | Latin | Czechia, Sweden |
| Glucophage | Latin | Czechia, South Africa |
| Metformin Orifarm | Latin | Sweden |
| Metformin Teva | Latin | Czechia, Sweden |
| APX-METFORMIN | Latin | Australia |
| BROTMIN | Latin | Czechia |
| Diaformin Viatris | Latin | Australia |
| Glucophage Xr | Latin | Czechia, South Africa |
| METFORMIN MEDREG | Latin | Czechia |
| METFORMIN MYLAN | Latin | Czechia |
| METFORMIN-WGR | Latin | Australia |
| STADAMET | Latin | Czechia |
| STADAMET NEO | Latin | Czechia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.